WESBURY, N.Y. (PRWEB) October 07, 2020
Entitled “Driving the Future of Pharma,” the event’s focus will be on steering the future of pharmaceutical science and manufacturing toward a more global, synchronized, and quality-driven industry. As the ISPE’s signature event, the 2020 ISPE Annual Meeting and Expo attracts pharmaceutical and biopharmaceutical professionals at all levels of the industry from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies.
Among the speakers featured at the event’s Opening Plenary Session on Monday, November 2nd will be Frances (Fran) Zipp, President and CEO of Lachman Consultants, and Chair of the ISPE 2019 – 2020 International Board of Directors. She was elected to the ISPE Board of Directors in 2013. As an acknowledged expert in compliance enhancement, and in addition to her executive duties at Lachman Consultants, Ms. Zipp assists and counsels senior-level management in areas of Corporate Governance, Corporate Integrity Agreement Compliance, Consent Decree Negotiations and Resolutions, Application Integrity Policy resolution, Due Diligence evaluations (facilities; products; technologies), and more.
As a regular exhibitor at the ISPE Annual Conference & Expo year-after-year, Lachman Consultants has showcased some of their most impactful innovations in consultant services designed to overcome the challenges imposed on the Life Sciences. In 2020, Lachman’s experience has helped their clients reduce the effects of the current pandemic significantly as they continue to provide innovative solutions. Among them are remote virtual inspections, and Lachman OnCall™ Good Manufacturing Practice (GMP) Teleconsulting, which provides faster responses to clients’ urgent life science questions. This new service offers clients a way to speak with Subject Matter Experts (SMEs) to get their most pressing questions answered quickly as the need arises.
Lachman Consultants has recently updated its website to feature the previously mentioned services so that their customers around the globe are able to easily engage with the company and take advantage of expert compliance, regulatory, and science & technology consulting services whether near or far.
ABOUT THE 2020 ISPE ANNUAL MEETING AND EXPO
(Excerpt from ISPE.org)
Virtual Conference 2-6 Nov. “Driving the Future of Pharma.”
We continue to monitor the unfolding global impact of COVID-19, and as the world evolves, so do we. We are transforming this event to be fully digital. The 2020 ISPE Annual Meeting & Expo will focus on steering the future of pharmaceutical science and manufacturing toward a more global, synchronized, and quality-driven industry. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies.
ABOUT LACHMAN CONSULTANTS
Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver highly effective and proven solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which have been shown to consistently exceed client requirements and expectations. Visit https://www.lachmanconsultants.com for more information.
For additional press information, please contact:
Ilena Della Ventura